Filing Details
- Accession Number:
- 0001209191-20-008882
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-02-12 17:20:21
- Reporting Period:
- 2020-02-10
- Accepted Time:
- 2020-02-12 17:20:21
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 875320 | Vertex Pharmaceuticals Inc / Ma | VRTX | Pharmaceutical Preparations (2834) | 043039129 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1661567 | Michael Parini | C/O Vertex Pharmaceuticals Incorporated 50 Northern Avenue Boston MA 02210 | Evp, Cl&Ao | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2020-02-10 | 13,458 | $240.95 | 54,788 | No | 4 | F | Direct | |
| Common Stock | Disposition | 2020-02-11 | 922 | $243.42 | 53,866 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-02-11 | 2,102 | $244.67 | 51,764 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-02-11 | 6,232 | $245.62 | 45,532 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-02-11 | 3,783 | $246.52 | 41,749 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-02-11 | 2,499 | $247.62 | 39,250 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-02-11 | 1,344 | $248.52 | 37,906 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | F | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- Transaction made pursuant to Mr. Parini's company-approved trading plan under Rule 10b5-1.
- Open market sales reported on this line occurred at a weighted average price of $243.42 (range $242.88 to $243.81).
- Mr. Parini undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
- Open market sales reported on this line occurred at a weighted average price of $244.67 (range $243.94 to $244.93).
- Open market sales reported on this line occurred at a weighted average price of $245.62 (range $245.12 to $246.11).
- Open market sales reported on this line occurred at a weighted average price of $246.52 (range $246.14 to $247.11).
- Open market sales reported on this line occurred at a weighted average price of $247.62 (range $247.14 to $248.08).
- Open market sales reported on this line occurred at a weighted average price of $248.52 (range $248.23 to $248.93).
Billionaire Hedge Funds
